Stem cells and breast cancer

Histopathology

Volumn 52, Issue 1, 2008, Pages 99-107

  Cariati, M ^a   Purushotham, A D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Breast cancer; Stem cells

Indexed keywords

ALPHA6 INTEGRIN; BETA1 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CD24 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; HERMES ANTIGEN; MUCIN 1;

BREAST CANCER; BREAST EPITHELIUM; CANCER STEM CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL INTERACTION; CELL PROLIFERATION; DIFFERENTIATED LARGE LIGHT CELL; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HUMAN; LARGE DARK CELL; MAMMARY GLAND; PRIORITY JOURNAL; REVIEW; SMALL LIGHT CELL; STEM CELL; UNDIFFERENTIATED LARGE LIGHT CELL;

BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 37249001827     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02895.x     Document Type: Review

References (74)

1. Seaberg RM, Van Der Kooy D. Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci. 2003 26 125 131.
2. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990 110 1001 1020.
3. Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell 2006 124 1111 1115.
4. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34 low/negative stem cell. Science 1996 273 242 245.
5. Janes SM, Lowell S, Hutter C. Epidermal stem cells. J. Pathol. 2002 197 479 491.
6. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 2002 24 91 98.
7. Morrison SJ, Qian D, Jerabek L et al. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol. 2002 168 635 642.
8. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001 414 98 104.
9. Miyagi K, Yamazaki T, Tsujino I et al. Application of hypothermia to autologous stem cell purging. Cryobiology 2001 42 190 195.
10. Woodward WA, Chen MS, Behbod F, Rosen JM. On mammary stem cells. J. Cell Sci. 2005 118 3585 3594.
11. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977 197 461 463.
12. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994 367 645 648.
13. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumours. Cancer Res. 2003 63 5821 5828.
14. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. U. S. A. 2003 100 3983 3988.
15. Osborne MP. Breast anatomy and development. In Harris JR ed. Diseases of the breas, 2nd edn, Vol. 1. Philadelphia : Lippincott Williams & Wilkins, 2000 1 13.
16. Henninghausen L, Robinson GW. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 1998 12 449 455.
17. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM. An atlas of mouse mammary gland development. J. Mammary Gland Biol. Neoplasia 2000 5 227 241.
18. Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 1983 97 274 290.
19. Shackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature 2006 439 84 88.
20. DeOme KB, Faulkin LJJ, Bern HA, Blair PB. Development of mammary tumours from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female CH3 mice. Cancer Res. 1959 19 515 520.
21. Hoshino K, Gardner WU. Transplantability and life span of mammary gland during serial transplantation in mice. Nature 1967 213 193 194.
22. Smith GH, Strickland P, Daniel CW. Putative epithelial stem cell loss corresponds with mammary growth senescence. Cell Tissue Res. 2002 10 313 320.
23. Young LJ, Medina D, DeOme KB, Daniel CW. The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp. Gerontol. 1971 6 49 56.
24. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998 125 1921 1930.
25. Chepko G, Smith GH. Three division-competent, structurally distinct cell populations contribute to mammary epithelial renewal. Tissue Cell 1997 29 239 253.
26. Smith GH. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. 1996 39 21 31.
27. Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA, Smith HS. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res. 1996 56 402 404.
28. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996 274 2057 2059.
29. Frank SA, Nowak MA. Cell biology: developmental predisposition to cancer. Nature 2003 422 494.
30. Novelli M, Cossu A, Oukrif D et al. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc. Natl Acad. Sci. U. S. A. 2003 100 3311 3314.
31. Diallo R, Schaefer KL, Poremba C et al. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J. Pathol. 2001 193 27 32.
32. Stingl J, Eirew P, Ricketson I et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006 439 993 997.
33. Smith CA, Monaghan P, Neville AM. Basal clear cells of the normal human breast. Virchows Arch. A Pathol. Anat. Histopathol. 1984 402 319 329.
34. Smith GH. Label-retaining epithelial cells in the mammary gland divide asymmetrically and retain their template DNA strands. Development 2005 132 681 687.
35. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 2002 245 42 56.
36. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine haematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996 183 1797 1806.
37. Clayton H, Titley I, Vivanco M. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp. Cell Res. 2004 297 444 460.
38. Petersen TW, Ibrahim SF, Diercks AH, van den Engh G. Chromatic shifts in the fluorescence emitted by murine thymocytes stained with Hoechst 33342. Cytometry A 2004 60 173 181.
39. Clarke RB, Spence K, Anderson E, Howell A, Okano H, Potten CS. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev. Biol. 2005 277 443 456.
40. Alvi AJ, Clayton H, Joshi C et al. Functional and molecular characterization of mammary side population cells. Breast Cancer Res. 2003 5 R1 R8.
41. Dontu G, Abdallah WM, Foley JM et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003 17 1253 1270.
42. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse haematopoietic stem cells. Science 1988 241 58 62.
43. Stingl J, Eaves CJ, Kuusk U, Emerman JT. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 1998 63 201 213.
44. Stingl J, Eaves CJ, Zandieh I, Emerman JT. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 2001 67 93 109.
45. Gudjonsson T, Villadsen R, Nielsen HL, Ronnov-Jessen L, Bissel MJ, Petersen OW. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002 16 693 706.
46. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res. 2006 8 R7.
47. Simian M, Hiray Y, Navre M, Werb Z, Lochter A, Bissel MJ. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001 128 3117 3131.
48. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001 409 633 637.
49. Muschler J, Lochter A, Roskelley CD, Yurchenco P, Bissel MJ. Division of labor among the alpha6beta4 integrin, beta1 integrins, and E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 1999 10 2817 2828.
50. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 1996 175 1 13.
51. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997 3 730 737.
52. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl Acad. Sci. U. S. A. 2000 97 7521 7526.
53. Fidler IJ, Kripke ML. Metastasis results from pre-existing variant cells within a malignant tumour. Science 1977 197 893 895.
54. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 1982 217 998 1003.
55. Nowell PC. Mechanisms of tumour progression. Cancer Res. 1986 46 2203 2207.
56. Heppner GH. Tumor heterogeneity. Cancer Res. 1984 44 2259 2265.
57. Weisenthal LM, Lippman ME. Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat. Rep. 1985 69 615 632.
58. Masters JR. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 2000 1 233 236.
59. Ponti D, Costa A, Zaffaroni N et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/cell progenitors. Cancer Res. 2005 65 5506 5511.
60. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44 + breast cancer-initiating cells to radiation. J. Natl Cancer Inst. 2006 98 1777 1785.
61. Cariati M, Naderi A, Brown JP et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF-7 breast cancer cell line. Int. J. Cancer 2007 122 298 304.
62. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin. Cancer Res. 2005 11 1154 1159.
63. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 2005 115 1503 1521.
64. Shipitsin M, Campbell LL, Argani P et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007 11 259 273.
65. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumours contain neural-stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002 39 193 206.
66. Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumours. Proc. Natl Acad. Sci. U. S. A. 2003 100 15178 15183.
67. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004 432 324 331.
68. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004 118 409 418.
69. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005 121 465 477.
70. Liu S, Dontu G, Mantle ID et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006 66 6063 6071.
71. Li Y, Welm B, Podsypanina K et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl Acad. Sci. U. S. A. 2003 100 15853 15858.
72. Costello RT, Mallet F, Gaugler B et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 2000 60 4403 4411.
73. Norgaard JM, Olesen LH, Hokland P. Changing picture of cellular drug resistance in human leukemia. Crit. Rev. Oncol. Hematol. 2004 50 39 49.
74. Doyle LA, Yang W, Abruzzo LV et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl Acad. Sci. U. S. A. 1998 95 15665 15670.